AGP Executive Report
Last update: 11 hours agoMedical Cannabis Research: A UK observational study reports sustained improvements for inflammatory arthritis patients using cannabis-based medical preparations, with mostly mild side effects and fewer than 15% reporting adverse events over 24 months. Regulation Watch: Missouri is proposing cannabis facility rule changes covering ownership, microbusiness transfers, recall procedures, and how prior violations could affect participation; New Mexico’s regulators have opened dozens of active criminal cannabis-related cases, including an unlicensed operation with 21,000 pounds found in greenhouses. Industry Moves: SOMAÍ launched its Soma OG medical cannabis flower in Switzerland via Dascoli Pharma, adding three indoor cultivars to a regulated supply chain. Enforcement & Public Safety: Coventry police charged a man after discovering a cannabis farm with 100+ plants and illegal electricity use; another Coventry incident is causing traffic delays near a busy junction. Policy & Access: Manitoba introduced a bill allowing cannabis stores to remove window coverings to improve employee safety and reduce isolation during higher-risk hours. Local Business Fallout: Nambour’s long-promised CBD streetscape revamp is delayed again after tender timelines slipped, frustrating local businesses.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.